AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 112 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,813 | -22.9% | 7,024 | +34.0% | 0.00% | 0.0% |
| Q2 2023 | $58,134 | -27.8% | 5,242 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $80,465 | -15.0% | 5,242 | +22.4% | 0.00% | -25.0% |
| Q4 2022 | $94,696 | +60.5% | 4,281 | +16.7% | 0.00% | +33.3% |
| Q3 2022 | $59,000 | +11.3% | 3,667 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $53,000 | 0.0% | 3,667 | +27.0% | 0.00% | 0.0% |
| Q1 2022 | $53,000 | -23.2% | 2,887 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $69,000 | -2.8% | 2,887 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $71,000 | +16.4% | 2,887 | +16.4% | 0.00% | +50.0% |
| Q2 2021 | $61,000 | +13.0% | 2,480 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $54,000 | +50.0% | 2,480 | +74.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | -10.0% | 1,425 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $40,000 | – | 1,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |